Search Results - "COUZI, L."

Kidney Intragraft Donor‐Specific Antibodies as Determinant of Antibody‐Mediated Lesions and Poor Graft Outcome by Bachelet, T., Couzi, L., Lepreux, S., Legeret, M., Pariscoat, G., Guidicelli, G., Merville, P., Taupin, J.‐L.

“…Allograft pathology, antibody–tissue interaction as demonstrated by C4d deposition and serological evidence of donor‐specific antibodies (DSA) are the cardinal…”
Get full text

Increased risk of mortality in systemic sclerosis‐associated digital ulcers: a systematic review and meta‐analysis by Meunier, P., Dequidt, L., Barnetche, T., Lazaro, E., Duffau, P., Richez, C., Couzi, L., Truchetet, M.‐E., Seneschal, J.

“…Background Survival can be threatened in certain forms of systemic sclerosis (SSc) so clear prognostic factors are needed. Objectives The aim of this…”
Get full text

Prevalence, distribution and amplitude of the complement interference phenomenon in single antigen flow beads assays by Guidicelli, G., Visentin, J., Franchini, N., Borg, C., Merville, P., Couzi, L., Taupin, J.‐L.

“…HLA antibody detection with single antigen flow beads (SAFB) assays is impaired by complement interference whose frequency, predictability and distribution…”
Get full text

High Incidence of Anticytomegalovirus Drug Resistance Among D+R− Kidney Transplant Recipients Receiving Preemptive Therapy by Couzi, L., Helou, S., Bachelet, T., Moreau, K., Martin, S., Morel, D., Lafon, M. E., Boyer, B., Alain, S., Garrigue, I., Merville, P.

“…Anti‐cytomegalovirus (CMV) prophylaxis is recommended in D+R− kidney transplant recipients (KTR), but is associated with a theoretical increased risk of…”
Get full text

Renal ultrasound elastography by Grenier, N, Gennisson, J.-L, Cornelis, F, Le Bras, Y, Couzi, L

“…Abstract Chronic kidney disease (CKD) incidence and prevalence are increasing in Western countries, due particularly to diabetes mellitus and…”
Get full text

Anti‐Cw Donor‐specific Alloantibodies Can Lead to Positive Flow Cytometry Crossmatch and Irreversible Acute Antibody‐Mediated Rejection by Bachelet, T., Couzi, L., Guidicelli, G., Moreau, K., Morel, D., Merville, P., Taupin, J.‐L.

Get full text

Easier Control of Late‐Onset Cytomegalovirus Disease Following Universal Prophylaxis Through an Early Antiviral Immune Response in Donor‐Positive, Recipient‐Negative Kidney Transplants by Kaminski, H., Couzi, L., Garrigue, I., Moreau, J.‐F., Déchanet‐Merville, J., Merville, P.

“…Universal prophylaxis for cytomegalovirus (CMV) prevention is viable but, compared with a preemptive strategy, leads to higher incidence of late‐onset disease…”
Get full text

Cytomegalovirus DNAemia Requiring (Val)Ganciclovir Treatment for More Than 8 Weeks Is a Key Factor in the Development of Antiviral Drug Resistance by Acquier, M, Taton, B, Alain, S, Garrigue, I, Mary, J, Pfirmann, P, Visentin, J, Hantz, S, Merville, P, Kaminski, H, Couzi, L

“…Abstract Background Prolonged (val)ganciclovir [(V)GCV] exposure for ≥6 weeks is a known predisposing factor for cytomegalovirus (CMV) drug resistance…”
Get full text

Cytomegalovirus‐Induced γδ T Cells During Rejection: An Ambivalent T Cell by Bachelet, T., Merville, P., Dechanet‐Merville, J., Couzi, L.

Get full text

Embolization of renal arteries before transplantation in patients with polycystic kidney disease: a single institution long-term experience by Petitpierre, F., Cornelis, F., Couzi, L., Lasserre, A. S., Tricaud, E., Le Bras, Y., Merville, P., Combe, C., Ferriere, J. M., Grenier, N.

“…Purpose We aimed to retrospectively assess the long-term safety and efficacy of embolization of renal arteries (ERA) in patients with polycystic kidney disease…”
Get full text

Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation by Taton, B., Moreau, K., Lepreux, S., Bachelet, T., Trimoulet, P., De Ledinghen, V., Pommereau, A., Ronco, P., Kamar, N., Merville, P., Couzi, L.

“…Hepatitis E virus (HEV) has been identified as a cause of chronic viral hepatitis in immunocompromised patients. Some glomerular diseases were found to be…”
Get full text

Renal Transplantation in Patients With AA Amyloidosis Nephropathy: Results From a French Multicenter Study by Kofman, T., Grimbert, P., Canouï‐Poitrine, F., Zuber, J., Garrigue, V., Mousson, C., Frimat, L., Kamar, N., Couvrat, G., Bouvier, N., Albano, L., Le Thuaut, A., Pillebout, E., Choukroun, G., Couzi, L., Peltier, J., Mariat, C., Delahousse, M., Buchler, M., Le Pogamp, P., Bridoux, F., Pouteil‐Noble, C., Lang, P., Audard, V.

“…Although end‐stage renal disease related to AA amyloidosis nephropathy is well characterized, there are limited data concerning patient and graft outcome after…”
Get full text

Embolization of renal arteries before transplantation in patients with polycystic kidney disease: a single institution long-term experience by Cornelis, F, Petitpierre, F, Le Bras, Y, Lasserre, A, Couzi, L, Combes, C, Merville, P, Ferrière, J, Grenier, N

Get full text

Renal Allografts with IF/TA Display Distinct Expression Profiles of Metzincins and Related Genes by Rödder, S., Scherer, A., Raulf, F., Berthier, C. C., Hertig, A., Couzi, L., Durrbach, A., Rondeau, E., Marti, H.‐P.

“…Chronic renal allograft injury is often reflected by interstitial fibrosis (IF) and tubular atrophy (TA) without evidence of specific etiology. In most…”
Get full text

Two-year post-transplantation cytomegalovirus DNAemia in asymptomatic kidney transplant recipients: incidence, risk factors, and outcome by Viot, B., Garrigue, I., Taton, B., Bachelet, T., Moreau, J.-F., Dechanet-Merville, J., Merville, P., Couzi, L.

“…Background The incidence and the impact of asymptomatic cytomegalovirus (CMV) DNAemia occurring after the first year post transplantation is unknown. Methods…”
Get full text

Embolization of Polycystic Kidneys as an Alternative to Nephrectomy Before Renal Transplantation: A Pilot Study by Cornelis, F., Couzi, L., Le Bras, Y., Hubrecht, R., Dodré, E., Geneviève, M., Pérot, V., Wallerand, H., Ferrière, J. M., Merville, P., Grenier, N.

“…In autosomal polycystic kidney disease, nephrectomy is required before transplantation if kidney volume is excessive. We evaluated the effectiveness of…”
Get full text

An acquired inhibitor to the GPVI platelet collagen receptor in a patient with lupus nephritis by NURDEN, P., TANDON, N., TAKIZAWA, H., COUZI, L., MOREL, D., FIORE, M., PILLOIS, X., LOYAU, S., JANDROT‐PERRUS, M., NURDEN, A. T.

“…Background: GPVI is a major platelet collagen signaling receptor. In rare cases of immune thrombocytopenic purpura (ITP), autoantibodies to GPVI result in…”
Get full text

Mycophenolate Mofetil: A Possible Cause of Hemophagocytic Syndrome Following Renal Transplantation? by Raffray, L., Couzi, L., Viallard, J. F., Pellegrin, J. L., Augis, V., Vernant, J. P., Merville, P.

Get full text

Preemptive Therapy Versus Valgancyclovir Prophylaxis in Cytomegalovirus-positive Kidney Transplant Recipients Receiving Antithymocyte Globulin Induction by Couzi, L, Helou, S, Bachelet, T, Martin, S, Moreau, K, Morel, D, Lafon, M.E, Garrigue, I, Merville, P

“…Abstract International consensus guidelines on the management of cytomegalovirus (CMV) infections in kidney transplantation recommend the use of universal…”
Get full text

P.022 Human cytomegalovirus (HCMV) UL40 variability in renal transplant recipients by Lafon, M.E, Faure-Della Corte, M, Garrigue, I, Magnin, N, Couzi, L, Dechanet-Merville, J, Merville, P, Fleury, H

Get full text